Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Clavulanic Acid Attenuated Cocaine Craving in Individuals with Cocaine Use Disorder.
Journal: Psychopharmacology bulletin
Published: March 13, 2026
Efficacy signals in a 12-week trial of clavulanic acid to decrease cocaine use.
Journal: Drug and alcohol dependence
Published: December 05, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorder.
Journal: The American journal of drug and alcohol abuse
Published: October 29, 2025
Testing the Efficacy of an Adaptive Approach to Delivering Psychosocial Interventions in Office-based Buprenorphine Treatment.
Journal: Journal of addiction medicine
Published: July 18, 2025
Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: March 04, 2025
Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, Canada.
Journal: Addiction (Abingdon, England)
Published: January 15, 2025
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.
Journal: JAMA
Published: October 17, 2024
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl.
Journal: JAMA network open
Published: September 27, 2024
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder.
Journal: Addiction science & clinical practice
Published: April 26, 2024
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment.
Journal: Journal of addiction medicine
Published: October 03, 2023
Last Updated: 09/26/2026